Schmiegelow K - Search Results

1

Incorporation of 6-thioguanine nucleotides into DNA during maintenance therapy of childhood acute lymphoblastic leukemia-the influence of thiopurine methyltransferase genotypes.

Ebbesen MS, Nersting J, Jacobsen JH, Frandsen TL, Vettenranta K, Abramsson J, Wesenberg F, Schmiegelow K. Ebbesen MS, et al. Among authors: schmiegelow k. J Clin Pharmacol. 2013 Jun;53(6):670-4. doi: 10.1002/jcph.81. Epub 2013 Apr 15. J Clin Pharmacol. 2013. PMID: 23585236 Clinical Trial. No abstract available.

2

Prognostic significance of methotrexate and 6-mercaptopurine dosage during maintenance chemotherapy for childhood acute lymphoblastic leukemia.

Schmiegelow K. Schmiegelow K. Pediatr Hematol Oncol. 1991 Oct-Dec;8(4):301-12. doi: 10.3109/08880019109028803. Pediatr Hematol Oncol. 1991. PMID: 1782110

3

Maintenance chemotherapy for childhood acute lymphoblastic leukemia: should dosage be guided by white blood cell counts?

Schmiegelow K, Pulczynska MK. Schmiegelow K, et al. Am J Pediatr Hematol Oncol. 1990 Winter;12(4):462-7. doi: 10.1097/00043426-199024000-00010. Am J Pediatr Hematol Oncol. 1990. PMID: 2285127

4

White-cell counts in childhood acute lymphoblastic leukemia.

Schmiegelow K, Pulczynska MK. Schmiegelow K, et al. Eur J Haematol. 1990 Jan;44(1):72-4. doi: 10.1111/j.1600-0609.1990.tb00351.x. Eur J Haematol. 1990. PMID: 2307222 No abstract available.

5

Prognostic significance of hepatotoxicity during maintenance chemotherapy for childhood acute lymphoblastic leukaemia.

Schmiegelow K, Pulczynska M. Schmiegelow K, et al. Br J Cancer. 1990 May;61(5):767-72. doi: 10.1038/bjc.1990.172. Br J Cancer. 1990. PMID: 2337515 Free PMC article.

6

6-Thioguanine nucleotide accumulation in red blood cells during maintenance chemotherapy for childhood acute lymphoblastic leukemia, and its relation to leukopenia.

Schmiegelow K, Bruunshuus I. Schmiegelow K, et al. Cancer Chemother Pharmacol. 1990;26(4):288-92. doi: 10.1007/BF02897232. Cancer Chemother Pharmacol. 1990. PMID: 2369793

7

Maintenance chemotherapy for childhood acute lymphoblastic leukemia: relation of bone-marrow and hepatotoxicity to the concentration of methotrexate in erythrocytes.

Schmiegelow K, Schrøder H, Pulczynska MK, Hejl M. Schmiegelow K, et al. Cancer Chemother Pharmacol. 1989;25(1):65-9. doi: 10.1007/BF00694341. Cancer Chemother Pharmacol. 1989. PMID: 2591003

8

White cell count during maintenance chemotherapy for standard-risk childhood acute lymphoblastic leukemia: relation to relapse rate.

Schmiegelow K, Pulczynska MK, Seip M. Schmiegelow K, et al. Pediatr Hematol Oncol. 1988;5(4):259-67. doi: 10.3109/08880018809037365. Pediatr Hematol Oncol. 1988. PMID: 3152971

9

Methotrexate and 6-mercaptopurine maintenance therapy for childhood acute lymphoblastic leukemia: dose adjustments by white cell counts or by pharmacokinetic parameters?

Schmiegelow K, Schrøder H, Schmiegelow M. Schmiegelow K, et al. Among authors: schmiegelow m. Cancer Chemother Pharmacol. 1994;34(3):209-15. doi: 10.1007/BF00685079. Cancer Chemother Pharmacol. 1994. PMID: 8004753

10

Pharmacokinetics, dose adjustments, and 6-mercaptopurine/methotrexate drug interactions in two patients with thiopurine methyltransferase deficiency.

Andersen JB, Szumlanski C, Weinshilboum RM, Schmiegelow K. Andersen JB, et al. Among authors: schmiegelow k. Acta Paediatr. 1998 Jan;87(1):108-11. doi: 10.1080/08035259850158001. Acta Paediatr. 1998. PMID: 9510461

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

534 results

Search Page